Skip to main content
. 2021 Jun 23;16:113. doi: 10.1186/s13014-021-01837-y

Table 1.

The target and the OARs constraint functions and dosimetric evaluation metrics

Site Target/OARs Prescription Constraints or objectives Dosimetric evaluation
NPC PTV70.4 70.4 Gy/32 F D95 > Prescription, D2 < 110% Prescription, uniform dose = Prescription V100, D95, D2
PTV66 66 Gy/32 F
PTV60 60 Gy/32 F
PTV54 54 Gy/32 F
Eyes / Max Dose < 50 Gy Max Dose
Lens / Max Dose < 25 Gy Max Dose
Brainstem / Max Dose < 54 Gy Max Dose
Temporal lobes / Max Dose < 65 Gy, V60 < 1% Max Dose
Spinal cord / Max Dose < 45 Gy Max Dose
Optic nerves / Max Dose < 54 Gy Max Dose
Larynx / Mean Dose < 45 Gy Mean Dose
Parotid / Mean Dose < 26 Gy Mean Dose, V30
Oral cavity / Mean Dose < 40 Gy Mean Dose
Temporomandibular joints / Max Dose < 70 Gy Not evaluated
Chiasm / Max Dose < 54 Gy Not evaluated
Rectum PTV 50 Gy/25 F D95 > Prescription, D2 < 110% Prescription, uniform dose = Prescription V100, D95, D2
Femoral heads / V40 < 40%, Max Dose < 50 Gy Mean Dose
Bladder / V40 < 50% Mean Dose, V40